Antimicrobial resistance programs in Canada 1995-2010: a critical evaluation

Antimicrobial Resistance and Infection Control

John M Conly¹ 

[1] Infection Prevention and Control, Foothills Medical Centre, Alberta Health Services, Calgary and Area, 1403-29th Street NW, Calgary, T2N 2T9, Canada

关键词: program components;    population;    prescribing;    scripts;    antibiotic;    stewardship;    antimicrobial resistance;   

Others  :  791348
DOI  :  10.1186/2047-2994-1-10

 received in 2011-12-23, accepted in 2012-02-14,  发布年份 2012

【 摘 要 】

Background

In Canada, systematic efforts for controlling antibiotic resistance began in 1997 following a national Consensus Conference. The Canadian strategy produced 27 recommendations, one of which was the formation of the Canadian Committee on Antibiotic Resistance (CCAR). In addition several other organizations began working on a national or provincial basis over the ensuing years on one or more of the 3 identified core areas of the strategy. Critical evaluation of the major programs within Canada which focused on antimicrobial resistance and the identified core components has not been previously conducted.

Findings

Data was collected from multiple sources to determine the components of four major AMR programs that were considered national based on their scope or in the delivery of their mandates. Assessment of program components was adapted from the report from the International Forum on Antibiotic Resistance colloquium. Most of the programs used similar tools but only the Do Bugs Need Drugs Program (DBND) had components directed towards day cares and schools. Surveillance programs for antimicrobial resistant pathogens have limitations and/or significant sources of bias. Overall, there has been a 25.3% decrease in oral antimicrobial prescriptions in Canada since 1995, mainly due to decreases in β lactams, sulphonamides and tetracyclines in temporal association with multiple programs with the most comprehensive and sustained national programs being CCAR and DBND.

Conclusions

Although there has been a substantial decrease in oral antimicrobial prescriptions in Canada since 1995, there remains a lack of leadership and co-ordination of antimicrobial resistance activities.

【 授权许可】

   
2012 Conly; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]World Health Organization: Overcoming antimicrobial resistance. [http://www.who.int/infectious-diseasereport/2000/index.html] webciteReport on infectious diseases 2000. (accessed Nov 1 2011)
• [2]WHO: World Health Day 2011 Policy briefs. [http://www.who.int/world-health-day/2011/policybriefs/en/] webcite 2011. (accessed Nov 1 2011)
• [3]Nugent R, Back E, Beith A: Center for Global Development Drug Resistance Working Group. Washington (D.C.): Center for Global Development The race against drug resistance; 2010.
• [4]Conly J: Antimicrobial resistance in Canada. CMAJ 2002, 167(8):885-91.
• [5]Health Canada: Controlling antimicrobial resistance: An integrated action plan for Canadians. Can Comm Dis Report 1997, 23(S7):1-32.
• [6]Finch RG, Metlay JP, Davey PG, Baker LJ, the International Forum on Antibiotic Resistance Colloquium: Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 2004, 4(1):44-53.
• [7]IMS Health [http://www.imshealthcanada.com] webcite (accessed Nov1 2011)
• [8]Statistics Canada [http://www.statcan.gc.ca/start-debut-eng.htm] webcite (accessed Nov1, 2011)
• [9]Stephen C, Parmley J, Dawson-Coates J, Fraser E, Conly J: Obstacles to developing a multi -national report card on antimicrobial resistance for Canada: an evidence based review. Microb Drug Resist 2007, 13:251-60.
• [10]Government of Canada: Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2008. Guelph, ON: Public Health Agency of Canada; 2011.
• [11]Hutchinson JM, Foley RN: Methods of physician remuneration and rates of antibiotic prescription. CMAJ 1999, 160:1013-7.
• [12]Blondel-Hill EM, Fryters SR, Mitchell S, Carson MM, Tomney M: Do bugs need drugs? A community project for the wise use of antibiotics. In Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco; 1999:735.
• [13]Stewart J, Pilla J, Dunn L: Pilot study for appropriate anti-infective community therapy; effect of a guideline-based strategy to optimize use of antibiotics. Can Fam Physician 2000, 46:851-9.
• [14]Weiss K, Blais R, Fortin A, Lantin S, Gaudet M: Impact of a multipronged education strategy on antibiotic prescribing in Quebec, Canada. Clin Infect Dis 2011, 53(5):433-9.